Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles

被引:30
作者
Li, Rutian [1 ,2 ]
Wu, Wei [3 ,4 ]
Liu, Qin [1 ,2 ]
Wu, Puyuan [1 ,2 ]
Xie, Li [1 ,2 ]
Zhu, Zhenshu [5 ]
Yang, Mi [1 ,2 ]
Qian, Xiaoping [1 ,2 ]
Ding, Yin [6 ]
Yu, Lixia [1 ,2 ]
Jiang, Xiqun [3 ,4 ]
Guan, Wenxian [7 ]
Liu, Baorui [1 ,2 ]
机构
[1] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China
[2] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China
[3] Nanjing Univ, Lab Mesoscop Chem, Nanjing 210008, Jiangsu, Peoples R China
[4] Nanjing Univ, Dept Polymer Sci & Engn, Coll Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China
[5] China Pharmaceut Univ, Dept Pharmaceut Anal, Nanjing, Jiangsu, Peoples R China
[6] Nanjing Univ, Sch Chem & Chem Engn, Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China
[7] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
MATRIX METALLOPROTEINASES; POOR-PROGNOSIS; CANCER-THERAPY; CONJUGATE; MMP-9; METASTASIS; EXPRESSION; INHIBITORS; CARCINOMA; EFFICACY;
D O I
10.1371/journal.pone.0069643
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aims: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. Materials and Methods: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. Results: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. Conclusion: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed.
引用
收藏
页数:11
相关论文
共 44 条
[1]   Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies [J].
Buergy, Daniel ;
Weber, Theresia ;
Maurer, Gabriele D. ;
Mudduluru, Giridhar ;
Medved, Fabian ;
Leupold, Joerg H. ;
Brauckhoff, Michael ;
Post, Stefan ;
Dralle, Henning ;
Allgayer, Heike .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) :894-901
[2]   Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models [J].
Chau, Y ;
Padera, RF ;
Dang, NM ;
Langer, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (06) :1519-1526
[3]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[4]   Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel [J].
Desai, N ;
Trieu, V ;
Yao, ZW ;
Louie, L ;
Ci, S ;
Yang, A ;
Tao, CL ;
De, T ;
Beals, B ;
Dykes, D ;
Noker, P ;
Yao, R ;
Labao, E ;
Hawkins, M ;
Soon-Shiong, P .
CLINICAL CANCER RESEARCH, 2006, 12 (04) :1317-1324
[5]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[6]   Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis [J].
Foda, HD ;
Zucker, S .
DRUG DISCOVERY TODAY, 2001, 6 (09) :478-482
[7]   Matrix metalloproteinases in cancer:: from new functions to improved inhibition strategies [J].
Folgueras, AR ;
Pendás, AM ;
Sánchez, LM ;
López-Otín, C .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) :411-424
[8]   A review of stimuli-responsive nanocarriers for drug and gene delivery [J].
Ganta, Srinivas ;
Devalapally, Harikrishna ;
Shahiwala, Aliasgar ;
Amiji, Mansoor .
JOURNAL OF CONTROLLED RELEASE, 2008, 126 (03) :187-204
[9]   Enzyme-Responsive Nanoparticle Systems [J].
Ghadiali, James E. ;
Stevens, Molly M. .
ADVANCED MATERIALS, 2008, 20 (22) :4359-4363
[10]   Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery [J].
Gullotti, Emily ;
Yeo, Yoon .
MOLECULAR PHARMACEUTICS, 2009, 6 (04) :1041-1051